PortfoliosLab logoPortfoliosLab logo
DOCT vs. BAPR
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

DOCT vs. BAPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) and Innovator U.S. Equity Buffer ETF - April (BAPR). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DOCT vs. BAPR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
DOCT
FT Vest U.S. Equity Deep Buffer ETF - October
-1.95%12.50%8.28%16.13%-5.27%6.89%145.69%
BAPR
Innovator U.S. Equity Buffer ETF - April
2.08%8.28%15.95%23.16%-7.04%12.58%3.54%

Returns By Period

In the year-to-date period, DOCT achieves a -1.95% return, which is significantly lower than BAPR's 2.08% return.


DOCT

1D
1.47%
1M
-2.34%
YTD
-1.95%
6M
0.52%
1Y
13.24%
3Y*
9.78%
5Y*
6.53%
10Y*

BAPR

1D
2.58%
1M
0.99%
YTD
2.08%
6M
4.42%
1Y
15.33%
3Y*
13.43%
5Y*
10.13%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DOCT vs. BAPR - Expense Ratio Comparison

DOCT has a 0.85% expense ratio, which is higher than BAPR's 0.79% expense ratio.


Return for Risk

DOCT vs. BAPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCT
DOCT Risk / Return Rank: 8383
Overall Rank
DOCT Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
DOCT Sortino Ratio Rank: 8383
Sortino Ratio Rank
DOCT Omega Ratio Rank: 8383
Omega Ratio Rank
DOCT Calmar Ratio Rank: 8181
Calmar Ratio Rank
DOCT Martin Ratio Rank: 8888
Martin Ratio Rank

BAPR
BAPR Risk / Return Rank: 8181
Overall Rank
BAPR Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
BAPR Sortino Ratio Rank: 7979
Sortino Ratio Rank
BAPR Omega Ratio Rank: 9292
Omega Ratio Rank
BAPR Calmar Ratio Rank: 6969
Calmar Ratio Rank
BAPR Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCT vs. BAPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) and Innovator U.S. Equity Buffer ETF - April (BAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DOCTBAPRDifference

Sharpe ratio

Return per unit of total volatility

1.48

1.29

+0.19

Sortino ratio

Return per unit of downside risk

2.20

1.99

+0.21

Omega ratio

Gain probability vs. loss probability

1.33

1.40

-0.07

Calmar ratio

Return relative to maximum drawdown

2.29

1.74

+0.55

Martin ratio

Return relative to average drawdown

11.15

11.59

-0.44

DOCT vs. BAPR - Sharpe Ratio Comparison

The current DOCT Sharpe Ratio is 1.48, which is comparable to the BAPR Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of DOCT and BAPR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DOCTBAPRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.48

1.29

+0.19

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.90

0.88

+0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

0.75

-0.25

Correlation

The correlation between DOCT and BAPR is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

DOCT vs. BAPR - Dividend Comparison

Neither DOCT nor BAPR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DOCT vs. BAPR - Drawdown Comparison

The maximum DOCT drawdown since its inception was -9.92%, smaller than the maximum BAPR drawdown of -23.91%. Use the drawdown chart below to compare losses from any high point for DOCT and BAPR.


Loading graphics...

Drawdown Indicators


DOCTBAPRDifference

Max Drawdown

Largest peak-to-trough decline

-9.92%

-23.91%

+13.99%

Max Drawdown (1Y)

Largest decline over 1 year

-5.90%

-9.19%

+3.29%

Max Drawdown (5Y)

Largest decline over 5 years

-9.92%

-15.58%

+5.66%

Current Drawdown

Current decline from peak

-2.93%

0.00%

-2.93%

Average Drawdown

Average peak-to-trough decline

-1.58%

-2.66%

+1.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.21%

1.38%

-0.17%

Volatility

DOCT vs. BAPR - Volatility Comparison

The current volatility for FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) is 2.75%, while Innovator U.S. Equity Buffer ETF - April (BAPR) has a volatility of 3.45%. This indicates that DOCT experiences smaller price fluctuations and is considered to be less risky than BAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DOCTBAPRDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.75%

3.45%

-0.70%

Volatility (6M)

Calculated over the trailing 6-month period

4.49%

4.26%

+0.23%

Volatility (1Y)

Calculated over the trailing 1-year period

8.96%

11.90%

-2.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

7.29%

11.54%

-4.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.33%

13.25%

+36.08%